21 February 2018

NICE, Level 1, City Tower, Piccadilly Plaza, Manchester, M1 4BT

Final agenda 

The meeting will start promptly at 10:00 and is expected to finish at approximately 17:00

Please note that this agenda is subject to change prior to the meeting.

  1. Welcome and introduction to format of meeting – Part 1 only (open session)
  2. Code of conduct for members of the public attending the meeting – Part 1 only (open session)
  3. Apologies – Part 1 only (open session)
  4. Any other business – Part 1 only (open session)
  5. Appraisal of cenegermin for treating neurotrophic keratitis [ID946]
    • 5.1. Declarations of interest – Part 1 only (open session)
    • 5.2. Introduction by the Chair, Stephen O’Brien – Part 1 only (open session)
    • 5.3. Presentation by the lead team, Richard Nicholas, Andrea Manca and Judith Wardle  Part 1 AND part 2 (open and closed session)
    • 5.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  6. Appraisal of crizotinib for treating ROS1-positive advanced non-small-cell lung cancer [ID1098]
               6.1. Declarations of interest – Part 1 only (open session)
               
    6.2.  Introduction by the Chair, Stephen O’Brien Part 1 only (open session)
               
    6.3.  Presentation by the Chair, Stephen O’Brien Part 1 AND part 2 (open and closed session)
               
    6.4.  Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) Part 2 only (closed session)
  7. Appraisal of atezolizumab for treating non-small-cell lung cancer after platinum-based chemotherapy [ID970]
    Following the committee meeting on 23 January 2018 for this topic, the committee suspended its Part 2a decision-making.
    Committee decision-making will resume in a Part 2b (committee-only) discussion at the meeting on 21 February 2018. Therefore this appraisal will not be open to the public. 
    • 6.1. Presentation by the Chair, Stephen O’Brien – Part 2 (closed session)
    • 6.2. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)

To print an agenda, please right click and select 'Print' from the menu.

Date, time and venue of next meeting

The next meeting will take place on Wednesday 21 March 2018 at 10:00am at NICE, Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT 

Please note all timings are approximate.

How to register

  • Click on the register link below and complete the registration form, selecting the topics you would like to attend.
  • You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.
  • Registration will close on Wednesday 7 February 2018 Please note that it may not be possible to accept late requests. 
  • Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Sandra Robinson.
  • Registrants wishing to conduct a research study on committee meetings and/or NICE processes will require prior permission. Contact the NICE Enquiry Handling team at nice@nice.org.uk.
  • Further information about conducting research is also available in our common questions and answers about meetings in public document.

 

Registration period: 24 January 2018 to 07 February 2018
Registration is closed.